Astra Signs Obesity Deal With CSPC Worth Up to $18.5 Billion
AstraZeneca Plc agreed an obesity drug deal with Chinese company CSPC Pharmaceutical Group Ltd. worth up to $18.5 billion, as the British drugmaker tries to push into the growing weight-loss...
By Ashleigh Furlong, Amber Tong · Bloomberg Markets
AstraZeneca Plc agreed an obesity drug deal with Chinese company CSPC Pharmaceutical Group Ltd. worth up to $18.5 billion, as the British drugmaker tries to push into the growing weight-loss market.